{"id": "0", "input": "Novartis hits acquisition trail  Swiss drugmaker Novartis has announced 5.65bn euros ($7.4bn; Â£3.9bn) of purchases to make its Sandoz unit the world biggest generic drug producer.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "hit-02"}, {"id": 2, "label": "acquire-01"}, {"id": 3, "label": "trail"}, {"id": 4, "label": "country"}, {"id": 5, "label": "make-01"}, {"id": 6, "label": "announce-01"}, {"id": 7, "label": "monetary-quantity"}, {"id": 8, "label": "euro"}, {"id": 9, "label": "purchase-01"}, {"id": 10, "label": "name", "properties": ["op1"], "values": ["switzerland"]}, {"id": 11, "label": "make-01"}, {"id": 12, "label": "company"}, {"id": 13, "label": "unit"}, {"id": 14, "label": "name", "properties": ["op1"], "values": ["sandoz"]}, {"id": 15, "label": "world"}, {"id": 16, "label": "big"}, {"id": 17, "label": "most"}, {"id": 18, "label": "have-degree-91"}, {"id": 19, "label": "generic"}, {"id": 20, "label": "drug"}, {"id": 21, "label": "produce-01"}, {"id": 22, "label": "name", "properties": ["op1"], "values": ["novartis"]}], "edges": [{"source": 7, "target": 8, "label": "unit"}, {"source": 1, "target": 3, "label": "arg1"}, {"source": 18, "target": 17, "label": "arg3"}, {"source": 9, "target": 7, "label": "arg3"}, {"source": 18, "target": 16, "label": "arg2"}, {"source": 6, "target": 9, "label": "arg1"}, {"source": 6, "target": 0, "label": "arg0"}, {"source": 12, "target": 14, "label": "name"}, {"source": 21, "target": 20, "label": "arg1"}, {"source": 0, "target": 22, "label": "name"}, {"source": 1, "target": 0, "label": "arg0"}, {"source": 11, "target": 0, "label": "arg0"}, {"source": 18, "target": 15, "label": "arg5"}, {"source": 9, "target": 0, "label": "arg0"}, {"source": 4, "target": 10, "label": "name"}, {"source": 19, "target": 20, "label": "domain"}, {"source": 9, "target": 11, "label": "purpose"}, {"source": 12, "target": 13, "label": "domain"}, {"source": 11, "target": 13, "label": "arg0"}, {"source": 18, "target": 13, "label": "arg1"}, {"source": 2, "target": 3, "label": "domain"}, {"source": 5, "target": 0, "label": "arg0"}], "tops": [6], "framework": "amr", "time": "2025-04-12"}
{"id": "1", "input": "Novartis, which last month forecast record sales for 2005, said it had bought all of Germany Hexal.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "last"}, {"id": 2, "label": "month"}, {"id": 3, "label": "forecast-01"}, {"id": 4, "label": "record"}, {"id": 5, "label": "sell-01"}, {"id": 6, "label": "name", "properties": ["op1"], "values": ["hexal"]}, {"id": 7, "label": "date-entity", "properties": ["year"], "values": ["2005"]}, {"id": 8, "label": "say-01"}, {"id": 9, "label": "buy-01"}, {"id": 10, "label": "all"}, {"id": 11, "label": "name", "properties": ["op1"], "values": ["germany"]}, {"id": 12, "label": "country"}, {"id": 13, "label": "company"}, {"id": 14, "label": "name", "properties": ["op1"], "values": ["novartis"]}], "edges": [{"source": 0, "target": 14, "label": "name"}, {"source": 9, "target": 0, "label": "arg0"}, {"source": 8, "target": 0, "label": "arg0"}, {"source": 8, "target": 9, "label": "arg1"}, {"source": 1, "target": 2, "label": "domain"}, {"source": 12, "target": 11, "label": "name"}, {"source": 3, "target": 5, "label": "arg1"}, {"source": 10, "target": 12, "label": "domain"}, {"source": 3, "target": 2, "label": "time"}, {"source": 9, "target": 13, "label": "arg1"}, {"source": 3, "target": 0, "label": "arg0"}, {"source": 4, "target": 5, "label": "domain"}, {"source": 5, "target": 7, "label": "time"}, {"source": 10, "target": 13, "label": "domain"}, {"source": 9, "target": 12, "label": "arg1"}], "tops": [8], "framework": "amr", "time": "2025-04-12"}
{"id": "2", "input": "It also acquired 67.7% of Hexal US affiliate Eon Labs, and offered to buy the remaining shares for $31 each.", "nodes": [{"id": 0, "label": "it"}, {"id": 1, "label": "also"}, {"id": 2, "label": "acquire-01"}, {"id": 3, "label": "percentage-entity", "properties": ["value"], "values": ["67.7"]}, {"id": 4, "label": "company"}, {"id": 5, "label": "country"}, {"id": 6, "label": "affiliate-01"}, {"id": 7, "label": "company"}, {"id": 8, "label": "name", "properties": ["op1"], "values": ["us"]}, {"id": 9, "label": "and"}, {"id": 10, "label": "offer-01"}, {"id": 11, "label": "buy-01"}, {"id": 12, "label": "name", "properties": ["op1", "op2"], "values": ["eon", "las"]}, {"id": 13, "label": "remain-01"}, {"id": 14, "label": "share"}, {"id": 15, "label": "dollar"}, {"id": 16, "label": "monetary-quantity", "properties": ["quant"], "values": ["31"]}, {"id": 17, "label": "each"}, {"id": 18, "label": "name", "properties": ["op1"], "values": ["hexal"]}], "edges": [{"source": 16, "target": 15, "label": "unit"}, {"source": 2, "target": 0, "label": "arg0"}, {"source": 9, "target": 2, "label": "op1"}, {"source": 13, "target": 14, "label": "arg1"}, {"source": 10, "target": 11, "label": "arg1"}, {"source": 2, "target": 3, "label": "arg1"}, {"source": 9, "target": 10, "label": "op2"}, {"source": 10, "target": 0, "label": "arg0"}, {"source": 11, "target": 0, "label": "arg0"}, {"source": 11, "target": 14, "label": "arg1"}, {"source": 6, "target": 7, "label": "arg1"}, {"source": 7, "target": 12, "label": "name"}, {"source": 4, "target": 18, "label": "name"}, {"source": 6, "target": 5, "label": "arg2"}, {"source": 11, "target": 16, "label": "arg3"}, {"source": 5, "target": 8, "label": "name"}, {"source": 1, "target": 2, "label": "domain"}, {"source": 17, "target": 16, "label": "domain"}], "tops": [9], "framework": "amr", "time": "2025-04-12"}
{"id": "3", "input": "Novartis said that it would be able to make cost savings of about $200m a year following the acquisitions.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "say-01"}, {"id": 2, "label": "possible-01"}, {"id": 3, "label": "cost-01"}, {"id": 4, "label": "save-01"}, {"id": 5, "label": "about"}, {"id": 6, "label": "dollar"}, {"id": 7, "label": "monetary-quantity", "properties": ["quant"], "values": ["200000000"]}, {"id": 8, "label": "rate-entity-91"}, {"id": 9, "label": "temporal-quantity", "properties": ["quant"], "values": ["1"]}, {"id": 10, "label": "year"}, {"id": 11, "label": "follow-01"}, {"id": 12, "label": "acquire-01"}, {"id": 13, "label": "name", "properties": ["op1"], "values": ["novartis"]}], "edges": [{"source": 0, "target": 13, "label": "name"}, {"source": 7, "target": 6, "label": "unit"}, {"source": 9, "target": 10, "label": "unit"}, {"source": 1, "target": 0, "label": "arg0"}, {"source": 8, "target": 9, "label": "arg2"}, {"source": 1, "target": 2, "label": "arg1"}, {"source": 5, "target": 7, "label": "op1"}, {"source": 4, "target": 0, "label": "arg0"}, {"source": 8, "target": 5, "label": "arg1"}, {"source": 11, "target": 12, "label": "arg2"}, {"source": 4, "target": 8, "label": "arg1"}, {"source": 11, "target": 4, "label": "arg1"}, {"source": 4, "target": 5, "label": "arg1"}, {"source": 2, "target": 4, "label": "arg1"}], "tops": [1], "framework": "amr", "time": "2025-04-12"}
{"id": "4", "input": "Novartis shares rose 1% to 57.85 Swiss francs in early trading.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "share"}, {"id": 2, "label": "rise-01"}, {"id": 3, "label": "percentage-entity", "properties": ["value"], "values": ["1"]}, {"id": 4, "label": "name", "properties": ["op1"], "values": ["switzerland"]}, {"id": 5, "label": "monetary-quantity", "properties": ["quant"], "values": ["57.85"]}, {"id": 6, "label": "country"}, {"id": 7, "label": "franc"}, {"id": 8, "label": "early"}, {"id": 9, "label": "trade-01"}, {"id": 10, "label": "name", "properties": ["op1"], "values": ["novartis"]}], "edges": [{"source": 0, "target": 10, "label": "name"}, {"source": 2, "target": 3, "label": "arg2"}, {"source": 6, "target": 4, "label": "name"}, {"source": 6, "target": 7, "label": "domain"}, {"source": 5, "target": 7, "label": "unit"}, {"source": 2, "target": 9, "label": "time"}, {"source": 2, "target": 1, "label": "arg1"}, {"source": 2, "target": 5, "label": "arg4"}, {"source": 0, "target": 1, "label": "domain"}, {"source": 8, "target": 9, "label": "domain"}, {"source": 1, "target": 0, "label": "poss"}, {"source": 9, "target": 8, "label": "time"}], "tops": [2], "framework": "amr", "time": "2025-04-12"}
{"id": "5", "input": "The deal will see Novartis Sandoz business overtake Israel Teva Pharmaceuticals as the world biggest maker of generics.", "nodes": [{"id": 0, "label": "deal"}, {"id": 1, "label": "see-01"}, {"id": 2, "label": "company"}, {"id": 3, "label": "business"}, {"id": 4, "label": "overtake-01"}, {"id": 5, "label": "company"}, {"id": 6, "label": "name", "properties": ["op1", "op2", "op3"], "values": ["israel", "teva", "pharmaceuticals"]}, {"id": 7, "label": "world"}, {"id": 8, "label": "big"}, {"id": 9, "label": "most"}, {"id": 10, "label": "have-degree-91"}, {"id": 11, "label": "company"}, {"id": 12, "label": "make-01"}, {"id": 13, "label": "generic"}, {"id": 14, "label": "name", "properties": ["op1", "op2"], "values": ["novartis", "sandoz"]}], "edges": [{"source": 1, "target": 0, "label": "arg0"}, {"source": 1, "target": 4, "label": "arg1"}, {"source": 10, "target": 9, "label": "arg3"}, {"source": 5, "target": 6, "label": "name"}, {"source": 2, "target": 14, "label": "name"}, {"source": 10, "target": 8, "label": "arg2"}, {"source": 12, "target": 11, "label": "arg0"}, {"source": 10, "target": 11, "label": "arg5"}, {"source": 4, "target": 3, "label": "arg0"}, {"source": 4, "target": 5, "label": "arg1"}, {"source": 12, "target": 13, "label": "arg1"}, {"source": 10, "target": 7, "label": "arg5"}, {"source": 11, "target": 7, "label": "location"}, {"source": 2, "target": 3, "label": "domain"}], "tops": [1], "framework": "amr", "time": "2025-04-12"}
{"id": "6", "input": "Based on 2004 figures the newly merged producer would have sales of more than $5bn, the company estimated.", "nodes": [{"id": 0, "label": "base-02"}, {"id": 1, "label": "date-entity", "properties": ["year"], "values": ["2004"]}, {"id": 2, "label": "figure"}, {"id": 3, "label": "new-01"}, {"id": 4, "label": "merge-01"}, {"id": 5, "label": "company"}, {"id": 6, "label": "produce-01"}, {"id": 7, "label": "sell-01"}, {"id": 8, "label": "more-than"}, {"id": 9, "label": "dollar"}, {"id": 10, "label": "monetary-quantity", "properties": ["quant"], "values": ["5000000000"]}, {"id": 11, "label": "company"}, {"id": 12, "label": "estimate-01"}], "edges": [{"source": 10, "target": 9, "label": "unit"}, {"source": 2, "target": 1, "label": "time"}, {"source": 8, "target": 10, "label": "op1"}, {"source": 7, "target": 8, "label": "arg3"}, {"source": 0, "target": 2, "label": "arg2"}, {"source": 3, "target": 4, "label": "arg1"}, {"source": 4, "target": 5, "label": "arg1"}, {"source": 12, "target": 11, "label": "arg0"}, {"source": 7, "target": 5, "label": "arg0"}, {"source": 6, "target": 5, "label": "arg0"}, {"source": 0, "target": 7, "label": "arg1"}, {"source": 12, "target": 7, "label": "arg1"}], "tops": [12], "framework": "amr", "time": "2025-04-12"}
{"id": "7", "input": "Novartis said that it would merge a number of departments, adding that there may be job cuts.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "say-01"}, {"id": 2, "label": "merge-01"}, {"id": 3, "label": "number"}, {"id": 4, "label": "department"}, {"id": 5, "label": "and"}, {"id": 6, "label": "add-01"}, {"id": 7, "label": "possible-01"}, {"id": 8, "label": "job"}, {"id": 9, "label": "cut-02"}, {"id": 10, "label": "name", "properties": ["op1"], "values": ["novartis"]}], "edges": [{"source": 0, "target": 10, "label": "name"}, {"source": 7, "target": 9, "label": "arg1"}, {"source": 4, "target": 3, "label": "quant"}, {"source": 9, "target": 8, "label": "arg1"}, {"source": 5, "target": 1, "label": "op1"}, {"source": 1, "target": 0, "label": "arg0"}, {"source": 6, "target": 0, "label": "arg0"}, {"source": 1, "target": 2, "label": "arg1"}, {"source": 5, "target": 6, "label": "op2"}, {"source": 6, "target": 7, "label": "arg1"}, {"source": 2, "target": 4, "label": "arg1"}, {"source": 2, "target": 0, "label": "arg0"}], "tops": [5], "framework": "amr", "time": "2025-04-12"}
{"id": "8", "input": "\"The strong growth outlook for Sandoz, which will create jobs, is expected to partially compensate for necessary reductions in the work force,\" the firm said in a statement.", "nodes": [{"id": 0, "label": "strong-02"}, {"id": 1, "label": "grow-01"}, {"id": 2, "label": "outlook"}, {"id": 3, "label": "product"}, {"id": 4, "label": "create-01"}, {"id": 5, "label": "job"}, {"id": 6, "label": "expect-01"}, {"id": 7, "label": "part"}, {"id": 8, "label": "compensate-01"}, {"id": 9, "label": "need-01"}, {"id": 10, "label": "reduce-01"}, {"id": 11, "label": "work-01"}, {"id": 12, "label": "force"}, {"id": 13, "label": "firm"}, {"id": 14, "label": "say-01"}, {"id": 15, "label": "state-01"}, {"id": 16, "label": "name", "properties": ["op1"], "values": ["sandoz"]}], "edges": [{"source": 8, "target": 7, "label": "degree"}, {"source": 14, "target": 6, "label": "arg1"}, {"source": 9, "target": 10, "label": "arg1"}, {"source": 3, "target": 16, "label": "name"}, {"source": 6, "target": 8, "label": "arg1"}, {"source": 8, "target": 10, "label": "arg1"}, {"source": 0, "target": 2, "label": "arg1"}, {"source": 8, "target": 2, "label": "arg0"}, {"source": 11, "target": 12, "label": "arg0"}, {"source": 4, "target": 5, "label": "arg1"}, {"source": 1, "target": 2, "label": "domain"}, {"source": 10, "target": 12, "label": "arg1"}, {"source": 14, "target": 13, "label": "arg0"}, {"source": 2, "target": 3, "label": "poss"}, {"source": 14, "target": 15, "label": "medium"}, {"source": 15, "target": 13, "label": "arg0"}], "tops": [14], "framework": "amr", "time": "2025-04-12"}
{"id": "9", "input": "Generic drugs are chemically identical to their more expensive branded rivals.", "nodes": [{"id": 0, "label": "generic"}, {"id": 1, "label": "drug"}, {"id": 2, "label": "chemical"}, {"id": 3, "label": "identical-01"}, {"id": 4, "label": "have-degree-91"}, {"id": 5, "label": "more"}, {"id": 6, "label": "expensive"}, {"id": 7, "label": "brand-01"}, {"id": 8, "label": "rival-01"}], "edges": [{"source": 0, "target": 1, "label": "domain"}, {"source": 4, "target": 6, "label": "arg2"}, {"source": 4, "target": 5, "label": "arg3"}, {"source": 3, "target": 1, "label": "arg1"}, {"source": 8, "target": 1, "label": "arg2"}, {"source": 2, "target": 3, "label": "domain"}, {"source": 3, "target": 2, "label": "manner"}, {"source": 7, "target": 1, "label": "arg1"}], "tops": [3], "framework": "amr", "time": "2025-04-12"}
{"id": "10", "input": "Producers such as Sandoz can copy the branded products usually after their patent protection expires and can sell them more cheaply as they do not have to pay research and development cost.", "nodes": [{"id": 0, "label": "company"}, {"id": 1, "label": "produce-01"}, {"id": 2, "label": "person"}, {"id": 3, "label": "company"}, {"id": 4, "label": "possible-01"}, {"id": 5, "label": "copy-01"}, {"id": 6, "label": "brand-01"}, {"id": 7, "label": "product"}, {"id": 8, "label": "usual"}, {"id": 9, "label": "after"}, {"id": 10, "label": "patent-01"}, {"id": 11, "label": "protect-01"}, {"id": 12, "label": "expire-01"}, {"id": 13, "label": "and"}, {"id": 14, "label": "possible-01"}, {"id": 15, "label": "sell-01"}, {"id": 16, "label": "have-degree-91"}, {"id": 17, "label": "more"}, {"id": 18, "label": "cheap-02"}, {"id": 19, "label": "cause-01"}, {"id": 20, "label": "obligate-01", "properties": ["polarity"], "values": ["-"]}, {"id": 21, "label": "pay-01"}, {"id": 22, "label": "research-01"}, {"id": 23, "label": "and"}, {"id": 24, "label": "develop-02"}, {"id": 25, "label": "monetary-quantity"}, {"id": 26, "label": "cost-01"}, {"id": 27, "label": "name", "properties": ["op1"], "values": ["sandoz"]}], "edges": [{"source": 1, "target": 2, "label": "arg0"}, {"source": 3, "target": 27, "label": "name"}, {"source": 9, "target": 12, "label": "op1"}, {"source": 11, "target": 10, "label": "arg2"}, {"source": 16, "target": 17, "label": "arg3"}, {"source": 19, "target": 20, "label": "arg0"}, {"source": 5, "target": 7, "label": "arg1"}, {"source": 16, "target": 18, "label": "arg2"}, {"source": 20, "target": 21, "label": "arg2"}, {"source": 26, "target": 25, "label": "arg2"}, {"source": 5, "target": 2, "label": "arg0"}, {"source": 5, "target": 9, "label": "time"}, {"source": 6, "target": 7, "label": "arg1"}, {"source": 15, "target": 7, "label": "arg1"}, {"source": 15, "target": 2, "label": "arg0"}, {"source": 21, "target": 2, "label": "arg0"}, {"source": 2, "target": 3, "label": "example"}, {"source": 21, "target": 25, "label": "arg1"}, {"source": 11, "target": 7, "label": "arg1"}, {"source": 14, "target": 15, "label": "arg1"}, {"source": 16, "target": 15, "label": "arg1"}, {"source": 1, "target": 0, "label": "arg0"}, {"source": 5, "target": 0, "label": "arg0"}, {"source": 20, "target": 2, "label": "arg1"}, {"source": 8, "target": 9, "label": "domain"}, {"source": 12, "target": 11, "label": "arg1"}, {"source": 18, "target": 15, "label": "arg1"}], "tops": [4], "framework": "amr", "time": "2025-04-12"}
{"id": "11", "input": "There are more than 150 generic drugmakers worldwide and analysts have predicted consolidation in a market that they call fragmented.", "nodes": [{"id": 0, "label": "more-than", "properties": ["op1"], "values": ["150"]}, {"id": 1, "label": "generic"}, {"id": 2, "label": "make-01"}, {"id": 3, "label": "worldwide"}, {"id": 4, "label": "and"}, {"id": 5, "label": "analyze-01"}, {"id": 6, "label": "person"}, {"id": 7, "label": "predict-01"}, {"id": 8, "label": "consolidate-01"}, {"id": 9, "label": "market"}, {"id": 10, "label": "call-01"}, {"id": 11, "label": "fragment-01"}], "edges": [{"source": 4, "target": 7, "label": "op2"}, {"source": 7, "target": 8, "label": "arg1"}, {"source": 5, "target": 6, "label": "arg0"}, {"source": 7, "target": 6, "label": "arg0"}, {"source": 8, "target": 9, "label": "arg1"}, {"source": 10, "target": 11, "label": "arg2"}, {"source": 10, "target": 6, "label": "arg0"}, {"source": 10, "target": 9, "label": "arg1"}, {"source": 11, "target": 9, "label": "arg1"}, {"source": 1, "target": 2, "label": "domain"}, {"source": 6, "target": 0, "label": "quant"}], "tops": [4], "framework": "amr", "time": "2025-04-12"}
{"id": "12", "input": "However, not all analysts were initially convinced about the deal.", "nodes": [{"id": 0, "label": "contrast-01"}, {"id": 1, "label": "all", "properties": ["polarity"], "values": ["-"]}, {"id": 2, "label": "analyze-01"}, {"id": 3, "label": "person"}, {"id": 4, "label": "initial"}, {"id": 5, "label": "convince-01"}, {"id": 6, "label": "deal-01"}], "edges": [{"source": 5, "target": 6, "label": "arg2"}, {"source": 5, "target": 4, "label": "time"}, {"source": 2, "target": 3, "label": "arg0"}, {"source": 0, "target": 5, "label": "arg2"}, {"source": 5, "target": 3, "label": "arg1"}, {"source": 1, "target": 3, "label": "domain"}], "tops": [0], "framework": "amr", "time": "2025-04-12"}
{"id": "13", "input": "\"This is a very expensive acquisition,\" Birgit Kuhlhoff, from Sal Oppenheim investment bank, told Reuters.", "nodes": [{"id": 0, "label": "this"}, {"id": 1, "label": "name", "properties": ["op1", "op2"], "values": ["sal", "oppenheim"]}, {"id": 2, "label": "very"}, {"id": 3, "label": "expensive"}, {"id": 4, "label": "acquire-01"}, {"id": 5, "label": "name", "properties": ["op1"], "values": ["reuters"]}, {"id": 6, "label": "bank"}, {"id": 7, "label": "tell-01"}, {"id": 8, "label": "publication"}, {"id": 9, "label": "person"}, {"id": 10, "label": "have-org-role-91"}, {"id": 11, "label": "name", "properties": ["op1", "op2"], "values": ["birgit", "kuhlhoff"]}], "edges": [{"source": 9, "target": 11, "label": "name"}, {"source": 10, "target": 9, "label": "arg0"}, {"source": 7, "target": 8, "label": "arg2"}, {"source": 7, "target": 9, "label": "arg0"}, {"source": 3, "target": 2, "label": "degree"}, {"source": 10, "target": 6, "label": "arg1"}, {"source": 3, "target": 4, "label": "domain"}, {"source": 4, "target": 0, "label": "arg1"}, {"source": 6, "target": 1, "label": "name"}, {"source": 8, "target": 5, "label": "name"}, {"source": 7, "target": 4, "label": "arg1"}], "tops": [7], "framework": "amr", "time": "2025-04-12"}
{"id": "14", "input": "\"I find it strange that they are making acquisitions in exactly those markets where they suffered price pressure.\"", "nodes": [{"id": 0, "label": "i"}, {"id": 1, "label": "find-02"}, {"id": 2, "label": "strange"}, {"id": 3, "label": "they"}, {"id": 4, "label": "acquire-01"}, {"id": 5, "label": "exact"}, {"id": 6, "label": "that"}, {"id": 7, "label": "market"}, {"id": 8, "label": "suffer-01"}, {"id": 9, "label": "price"}, {"id": 10, "label": "pressure-01"}], "edges": [{"source": 1, "target": 0, "label": "arg0"}, {"source": 1, "target": 2, "label": "arg1"}, {"source": 4, "target": 7, "label": "location"}, {"source": 4, "target": 3, "label": "arg0"}, {"source": 8, "target": 3, "label": "arg0"}, {"source": 2, "target": 4, "label": "domain"}, {"source": 8, "target": 10, "label": "arg1"}, {"source": 6, "target": 7, "label": "domain"}, {"source": 10, "target": 9, "label": "arg1"}, {"source": 5, "target": 7, "label": "domain"}], "tops": [1], "framework": "amr", "time": "2025-04-12"}
